The influence of initiation of progesterone supplementation in IVF-ET outcome-a prospective, randomized, controlled trial.

The influence of initiation of progesterone supplementation in IVF-ET outcome-a prospective, randomi

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-14005293

Enrollment

Unknown

Registered

2014-10-05

Start date

2014-10-10

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Two groups:initiation of progesterone one day after oocyte re

Eligibility

Inclusion criteria

Inclusion criteria: regular menstruation cycle between 25 and 30 days; age smaller than 38 years; serum basal follicle-stimulating hormone (FSH) concentration smaller than 15IU/L; the first IVF-ET cycle; no treatment with gonadotrophins within 3 months before the study.

Exclusion criteria

Exclusion criteria: polycystic ovarian syndrome (PCOS); endometriosis;uterine malformation; ovarian tumor; recurrent spontaneous abortion; abnormal chromosome; thyroid diseases; systemiclupuserythematosus(SLE)

Design outcomes

Primary

Measure	Time frame
pregnancy rate;	—

Secondary

Measure	Time frame
early abortion rate;implantation rate;	—

Countries

China

Contacts

Public ContactGao Jun

jungao1977@hotmail.com+86 13763336681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 8, 2026